Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.59 |
| ▸ | PRKCA | P17252 | 2/20 | 0.57 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.57 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.57 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.47 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.47 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862082 | 1.00 | DGKA (0.59) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL19862083 | 1.00 | DGKA (0.59) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL19862077 | 1.00 | DGKA (0.59) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL19862076 | 0.91 | LMNA (0.53) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL19862069 | 0.91 | LMNA (0.53) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL18204270 | 0.90 | DGKA (0.62) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL18204271 | 0.90 | DGKA (0.62) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL19862075 | 0.90 | DGKA (0.74) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL19862081 | 0.90 | DGKA (0.74) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL19862072 | 0.90 | DGKA (0.74) | DGKAPRKCAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767278-B2 | Plant extract compositions for forming protective coatings | APEEL TECHNOLOGY, INC. (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230232872-A1 | COMPOUNDS AND FORMULATIONS FOR PROTECTIVE COATINGS | APEEL TECHNOLOGY, INC. | 2023-07-27 | — | — | US | disclosed |
| US-11641865-B2 | Compounds and formulations for protective coatings | APEEL TECHNOLOGY, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-20180222835-A1 | Plant Extract Compositions for Forming Protective Coatings | APEEL TECHNOLOGY, INC. | 2018-08-09 | — | — | US | disclosed |
| US-20180044276-A1 | PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS | APEEL TECHNOLOGY, INC. | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222835-A1 | Plant Extract Compositions for Forming Protective Coatings | CUTA, SHARPIN, BROX | DGKA 3360/4885PRKCA 1628/4885PRKCE 1133/4885 |
| US-11767278-B2 | Plant extract compositions for forming protective coatings | CUTA, SHARPIN, BROX | DGKA 3360/4885PRKCA 1628/4885PRKCE 1133/4885 |
| US-20180044276-A1 | PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS | CUTA, SHARPIN, BROX | DGKA 3360/4885PRKCA 1628/4885PRKCE 1133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.